More and more of us are living with long-term MSK conditions, putting increasing pressure on our already over-stretched NHS and local services. Is the current model unsustainable? And what does the future of MSK care look like?
These were questions explored in the well-attended 2023 ARMA Annual Lecture. We were delighted to welcome two leading experts in their fields, Adam Lent, Chief Executive of New Local, and Laura Finucane, Consultant Physiotherapist and Clinical Director of Sussex MSK Partnership, who shared their insights with a lively audience.…
Read more of this article
Integrated Care Boards have been in place for almost a year now. Over that year, we have seen the profile and status of MSK health rising at a national level. It is difficult to tell if that profile is reflected at an ICB level. If not, then all the national profile in the world won’t make a difference to people with MSK conditions. That’s why ARMA is making local MSK services a priority with a new project, and we need you to get involved.… 
Versus Arthritis: Encouraging Physical Activity in the Management of Musculoskeletal Conditions
The trustees of The Ehlers-Danlos Support UK are delighted to announce that Susan Booth, recently Executive Director, Development at Target Ovarian Cancer, has been appointed to succeed Kay Julier. Susan will take up the position from 1 July and work alongside Kay from mid-June.
With a growing number of people affected by long-term MSK conditions, improving their quality of life has never been more important. Yet services are under increasing pressure, with lengthy backlogs, leaving many to believe our current models are unsustainable.